[1] |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(1):7-30.
doi: 10.3322/caac.v68.1
URL
|
[2] |
Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: An updated systematic analysis[J]. Lancet, 2015, 385(9965): 371-379.
doi: 10.1016/S0140-6736(14)60383-4
URL
|
[3] |
Weiss SL, Fitzgerald JC, Pappachan J, et al. Global epidemiology of pediatric severe sepsis: The sepsis prevalence, outcomes, and therapies study[J]. Am J Respir Crit Care Med, 2015, 191(10) : 1147-1157.
doi: 10.1164/rccm.201412-2323OC
URL
|
[4] |
Weiss SL, Peters MJ, Alhazzani W, et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children[J]. Intensive Care Med, 2020, 21(2):e52-e106.
|
[5] |
Maia RR, Wunsch FV. Infection and childhood leukemia: Review of evidence[J]. Rev Saude Publica, 2013, 47(6):1172-1185.
doi: 10.1590/S0034-89102013000901172
URL
|
[6] |
Klein K, Hasle H, Abrahamsson J, et al. Differences in infection prophylaxis measures between paediatric acute myeloid leukaemia study groups within the international Berlin-Frankfurt-Munster(I-BFM)study group[J]. Br J Haematol, 2018, 183(1):87-95.
doi: 10.1111/bjh.2018.183.issue-1
URL
|
[7] |
Pole JD, Gibson P, Ethier MC, et al. Evaluation of treatment-related mortality among paediatric cancer deaths: A population based analysis[J]. British journal of cancer, 2017, 116(4): 540-545.
doi: 10.1038/bjc.2016.443
pmid: 28095399
|
[8] |
Alexander S, Pole JD, Gibson P, et al. Classification of treatment-related mortality in children with cancer: A systematic assessment[J]. The Lancet Oncology, 2015, 16(16): e604-e610.
|
[9] |
Loeffen EAH, Knops RRG, Boerhof J, et al. Treatment-related mortality in children with cancer: Prevalence and risk factors[J]. Eur J Cancer, 2019, 121: 113-122.
doi: S0959-8049(19)30468-X
pmid: 31569066
|
[10] |
Ehrlich BS, McNeil MJ, Pham LTD, et al. Treatment-related mortality in children with cancer in low-income and middle-income countries: A systematic review and meta-analysis[J]. The Lancet Oncology, 2023, 24(9):967-977.
doi: 10.1016/S1470-2045(23)00318-2
URL
|
[11] |
陈芬, 安美玉, 姚彤, 等. 15例血液肿瘤患儿化疗后感染合并急性呼吸窘迫综合征回顾性分析[J]. 中国小儿血液与肿瘤杂志, 2020, (1):24-27.
|
[12] |
Mikulska M, Viscoli C, Orasch C, et al. Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients[J]. J Infect, 2014, 68(4):321-331.
doi: 10.1016/j.jinf.2013.12.006
pmid: 24370562
|
[13] |
Feld Ronald. Bloodstream infections in cancer patients with febrile neutropenia[J]. Int J Antimicrob Agents, 2008, 32:S30-S33.
doi: 10.1016/j.ijantimicag.2008.06.017
URL
|
[14] |
王坚敏, 汤静燕, 张蓓, 等. 儿童恶性肿瘤合并感染病原菌调查[J]. 中华医院感染学杂志, 2009, (9):354-357.
|
[15] |
Murray C, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis[J]. The Lancet, 2022, 399(10325):629-655.
doi: 10.1016/S0140-6736(21)02724-0
URL
|
[16] |
Averbuch D, Avaky C, Harit M, et al. Non-fermentative gram-negative rods bacteremia in children with cancer: A 14-year single-center experience[J]. Infection, 2017, 45(3):327-334.
doi: 10.1007/s15010-017-0988-1
pmid: 28205160
|
[17] |
Limmathurotsakul D, Dunachie S, Fukuda K, et al. Improving the estimation of the global burden of antimicrobial resistant infections[J]. Lancet Infect Dis, 2019, 19: e392-e398.
doi: 10.1016/S1473-3099(19)30276-2
|
[18] |
Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: A global multifaceted phenomenon[J]. Pathog Glob Health, 2015, 109: 309-318.
doi: 10.1179/2047773215Y.0000000030
pmid: 26343252
|
[19] |
Thaden JT, Park LP, Maskarinec SA, et al. Results from a 13-year prospective cohort study show increased mortality associated with bloodstream infections caused by pseudomonas aeruginosa compared to other bacteria[J]. Antimicrob Agents Chemother, 2017, 61(6):e02671-16.
|
[20] |
熊玲玲, 马琼, 袁有华, 等. 铜绿假单胞菌血流感染57例的死亡危险因素分析[J]. 中国感染与化疗杂志, 2021, 21(3):154-257.
|
[21] |
Satlin MJ, Jenkins SG, Walsh TJ. The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies[J]. Clin Infect Dis, 2014, 58:1274-1283.
doi: 10.1093/cid/ciu052
pmid: 24463280
|
[22] |
姚佳峰, 蔡思雨, 李楠, 等. 2016-2017年单中心血液肿瘤患儿感染病原菌分布的临床特点分析[J]. 北京医学, 2018, 40(4):301-304.
|
[23] |
王晓晖, 钱素云. PICU中央导管相关血流感染患儿的临床特点分析:单中心回顾性研究[J]. 中国小儿急救医学, 2019, 26(7):492-496.
|
[24] |
王文超, 王颖雯, 康琼芳, 等. 儿科中心静脉通路装置发生导管相关性血流感染危险因素的系统评价[J]. 2020, 15(4):261-268.
|
[25] |
王丹, 张娜, 邵静波, 等. 血液肿瘤患儿中心静脉导管相关血流感染的危险因素分析[J]. 中国感染与化疗杂志, 2022, 22(1):1-7.
doi: 10.16718/j.1009-7708.2022.01.001
|